REGN Gross Profit Growth
Regeneron Pharmaceuticals · Gross Profit Growth
REGN Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported8.38%period ending
REGN TTM Gross Profit YoY % (-154.00% → 8.38%)
Year-over-year change
High-resolution chart · PNG
REGN gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 8.381% | |
| 4.3783% | |
| 0.0875% | |
| 2.9916% | |
| 6.6554% | |
| 9.9869% | |
| 12.4084% | |
| 7.5513% | |
| 6.697% | |
| 4.4033% | |
| 4.5796% | |
| -3.5858% | |
| -9.3635% | |
| -23.0735% | |
| -22.0497% | |
| -0.6064% | |
| 12.3554% | |
| 76.7565% | |
| 86.9127% | |
| 70.5403% | |
| 68.5991% | |
| 29.266% | |
| 27.9298% | |
| 16.6274% | |
| 7.0572% | |
| 1.1787% | |
| -8.9137% | |
| -0.6944% | |
| 3.0308% | |
| 7.7282% | |
| 14.9873% | |
| 15.8078% | |
| 17.5787% | |
| 19.1173% | |
| 18.3327% | |
| 14.715% | |
| 12.9888% | |
| 14.8749% | |
| 21.3681% | |
| 26.0012% | |
| 36.6672% | |
| 42.4563% | |
| 41.9378% | |
| 42.4262% | |
| 33.8571% | |
| 32.8664% | |
| 34.1209% | |
| 37.3947% | |
| 43.294% | |
| 42.8114% | |
| 50.6458% | |
| 72.0634% | |
| 123.7124% | |
| 170.3809% | |
| 193.025% | |
| 126.4319% | |
| 58.1975% | |
| 17.8741% | |
| -3.364% | |
| 8.179% | |
| 6.0751% | |
| 14.8286% | |
| 21.0283% | |
| 24.9552% | |
| 51.6397% | |
| 58.685% | |
| 58.9638% | |
| 36.156% | |
| 39.503% | |
| 54.4105% | |
| 89.9852% | |
| 251.8745% | |
| 237.4789% | |
| 202.6552% | |
| 126.0791% | |
| 15.7359% | |
| -0.9387% | |
| -7.6967% | |
| -2.3572% | |
| -28.6079% | |
| -38.687% | |
| -47.4219% | |
| -64.3357% | |
| -37.3134% | |
| -17.4252% | |
| 9.5239% | |
| 201.5858% | |
| 282.0842% | |
| 332.7913% | |
| 383.4969% | |
| 239.6066% | |
| 128.0306% | |
| 87.7856% | |
| 41.7549% | |
| -14.9759% | |
| -39.4041% | |
| -56.1911% | |
| -65.1969% | |
| -58.2796% | |
| -42.7306% |